Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clin…
Biotechnology
US, Cambridge [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Mersana Therapeutics, Inc. (MRSN) to it's peer group.
Peer Group
CERE RVMD KURA CGEM RLAY AMLX SNDX XFOR DAWN HOOK PTGX VRDN REPL TERN INZY PLRX ABOS THRX RCUS
Compare Together
Loading...